king
-
Aging and Longevity
King’s College London Researchers Identify Potential Breakthrough in Alzheimer’s Treatment Through Dual-Action Drug KCL-286
In a significant advancement for neurodegenerative research, a team of scientists at King’s College London (KCL) has identified a promising…
Read More » -
Aging and Longevity
King’s College London Researchers Identify Breakthrough Multi-Target Drug Candidate KCL-286 for Early Stage Alzheimer’s Treatment
In a significant departure from traditional amyloid-centric research, a team of neuroscientists at King’s College London (KCL) has unveiled a…
Read More »
